SSRI withdrawal symptoms typically last one to two weeks, though they can range from a few days to several months depending on the medication, how long you took it, and how quickly you stopped. Symptoms usually begin within two to four days of your last dose or a significant dose reduction. For a smaller but meaningful number of people, withdrawal can stretch well beyond that initial window.
The Standard Timeline
Most people follow a fairly predictable pattern. Within two to four days of stopping an SSRI, the first symptoms appear. For the majority, these peak within the first week and then gradually fade over one to two weeks total. This is the acute withdrawal phase, and it covers the experience of most people who taper at a reasonable pace.
But “most people” doesn’t mean everyone. Some experience symptoms that linger for months. A large real-world trial found that people who discontinued antidepressants still reported significantly more withdrawal symptoms than those who stayed on medication at 12 weeks, 26 weeks, and even 39 weeks after stopping. So while the textbook answer is one to two weeks, the reality has a long tail.
Why Your Specific SSRI Matters
The single biggest factor in how quickly withdrawal hits and how long it lasts is your medication’s half-life, which is how long the drug stays active in your body. Once you stop taking an SSRI, your body clears whatever remains over roughly five half-lives. For most SSRIs, that’s about five days. But the differences between individual drugs are dramatic.
Paroxetine has a half-life of about one day, making it one of the fastest to leave your system and one of the most likely to cause withdrawal. Sertraline and escitalopram are similar, with half-lives of roughly 1.1 to 1.5 days. Fluoxetine is the outlier: the drug and its active breakdown product together have a half-life of four to sixteen days, meaning it can remain significantly active in your body for five or more weeks after your last dose. That built-in slow taper is why fluoxetine rarely causes withdrawal symptoms, especially at doses under 40 mg.
Clinicians sometimes use this to their advantage, switching patients from a shorter-acting SSRI to fluoxetine before discontinuing, essentially letting the drug taper itself.
What Withdrawal Actually Feels Like
SSRI withdrawal produces a distinctive mix of physical and psychological symptoms that can feel alarming if you don’t know what to expect. The hallmark symptom is “brain zaps,” brief electrical shock sensations in the head that many people describe as unmistakable. These don’t occur in depression relapse, which makes them a useful signal that what you’re experiencing is withdrawal.
Other common symptoms include dizziness, nausea, flu-like body aches, insomnia or vivid dreams, irritability, and a general sense of unsteadiness or poor coordination. Some people experience intense mood swings, sudden crying spells, or anxiety that feels different from their original condition. The combination of physical symptoms alongside emotional ones is characteristic of withdrawal and helps distinguish it from a return of the underlying depression.
When Withdrawal Lasts Longer Than Expected
Researchers now recognize a condition called post-acute withdrawal syndrome, or PAWS, defined as withdrawal symptoms persisting beyond six weeks. The duration varies enormously. In published studies, PAWS has been reported lasting anywhere from about six weeks to over thirteen years, though the extreme end of that range likely involves additional complicating factors.
One survey of people who sought help for withdrawal difficulties found that 50% reported symptoms lasting more than a year, 32% more than two years, and 11% more than five years. These numbers come from a self-selected group of people who were struggling enough to seek help, so they represent the more severe end of the spectrum rather than the average experience. Still, they make clear that prolonged withdrawal is not imaginary or rare among those affected.
The best controlled evidence comes from a pragmatic trial that tracked patients for 39 weeks after discontinuation and still found a statistically significant gap in withdrawal symptoms between those who stopped and those who continued their medication. This suggests that for some people, the brain’s adjustment process takes the better part of a year.
What Determines Your Risk
Three main factors predict how severe and prolonged your withdrawal is likely to be. The first is how long you’ve been on the medication. Longer use is associated with both a higher chance of withdrawal and more intense symptoms, consistent with the idea that the brain adapts more deeply the longer it’s exposed to the drug. The second factor is dose. Higher doses carry a somewhat increased risk, though this relationship has a ceiling effect, likely because serotonin receptors become mostly saturated beyond a certain dose. The third factor, as discussed above, is which specific SSRI you’re taking.
There’s also significant individual variation that these factors don’t fully explain. Two people on the same dose of the same drug for the same duration can have very different withdrawal experiences. Genetics, overall health, and the speed of the taper all play a role.
Why the Brain Needs Time to Adjust
SSRIs work by blocking the transporters that remove serotonin from the gaps between nerve cells, keeping serotonin levels elevated. Over months and years of use, the brain doesn’t just get used to this. It actually reduces the number of those transporters. When you stop the drug, the transporters are still depleted, so the brain can’t efficiently clear serotonin the way it normally would. This creates a temporary state of serotonin overactivity, which drives many of the physical symptoms.
Animal studies show that transporter density normalizes only gradually after discontinuation. The brain essentially needs to rebuild hardware that was downregulated during treatment. This biological reality is why abrupt stops cause the worst symptoms and why gradual tapering gives the brain time to readjust at each step.
How Tapering Reduces Withdrawal
The most effective strategy for minimizing withdrawal is a slow, gradual taper rather than stopping abruptly. But “gradual” doesn’t just mean cutting your dose in even steps. Newer guidance emphasizes what’s called hyperbolic tapering: making each dose reduction smaller than the last, particularly toward the end. This matters because the relationship between dose and effect on the brain isn’t linear. Dropping from 20 mg to 10 mg might reduce serotonin activity by a modest amount, but dropping from 10 mg to zero could slash it dramatically. Hyperbolic tapering keeps each step roughly equal in terms of its impact on brain chemistry.
In practice, this means the final stages of tapering often involve very small doses, sometimes smaller than what pharmaceutical companies manufacture as standard pills. Some people use liquid formulations or split tablets to achieve these reductions. There is no single taper schedule that works for everyone. Current best practice treats tapering as a highly personalized process, with the pace guided by how you’re actually feeling at each step rather than a fixed calendar. Some people taper over weeks, others over many months.
Withdrawal vs. Relapse
One of the trickiest aspects of stopping an SSRI is figuring out whether returning symptoms are withdrawal or a genuine relapse of depression. The distinction matters because the appropriate response is different. Several features help tell them apart.
Withdrawal typically starts within days of a dose reduction, includes physical symptoms like brain zaps, dizziness, and nausea that wouldn’t normally accompany depression, and follows a “wave” pattern of onset, peak, and gradual resolution. Relapse tends to develop more slowly, over weeks, and presents as a return of familiar depressive symptoms without the distinctive physical component. Another telling clue: if you restart the SSRI and symptoms resolve within a day or two, that rapid response points strongly toward withdrawal. A true depressive relapse would take weeks to respond to restarting medication.
How Common Withdrawal Really Is
Estimates of how many people experience withdrawal vary widely depending on how the question is studied. A 2024 analysis in The Lancet Psychiatry estimated that after subtracting placebo-like effects, roughly 15% of people experience withdrawal that’s genuinely drug-related, with about 1 in 35 experiencing severe symptoms. However, earlier reviews using survey data and naturalistic studies placed the figure much higher, between 50% and 57%. The gap likely reflects differences in methodology, definitions of withdrawal, and how carefully symptoms were measured. The practical takeaway: withdrawal is common enough that anyone stopping an SSRI should be aware of it, but severe or prolonged cases affect a smaller subset of people.